Robert Flanigan, MD

Article

Health-Related Quality of Life and Toxicity After Definitive High-Dose-Rate Brachytherapy Among Veterans With Prostate Cancer

Author:: Robert Flanigan, MD

Publish date: August 18, 2021

High-dose-rate brachytherapy as monotherapy is a well-tolerated treatment option for veterans with lowor intermediate-risk prostate cancer, with fa...